Cytori Therapeutics (CYTX +6%) moves up after announcing its begun its Athena clinical trial to...

|About: Cytori Therapeutics Inc (CYTX)|By:, SA News Editor

Cytori Therapeutics (CYTX +6%) moves up after announcing its begun its Athena clinical trial to investigate it's cell therapy in patients who suffer from a severe form of untreatable heart failure due to chronic myocardial ischemia. The first patient was treated at the Minneapolis Heart Institute Foundation in September and has already undergone a seven day follow-up assessment.